Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Cox

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Chest|February 29, 2024
The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung DiseaseSabina A Guler, Daniel-Costin Marinescu, Gerard Cox, et al.
Respiratory Medicine|April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung diseaseGiulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Annals of the American Thoracic Society|December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung DiseaseAlyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Respiratory Medicine|December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune featuresSana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 4, 2023
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who surviveXiaotian Ju, Kiho Son, Rameen Jamil, et al.
Respirology (Carlton, Vic.)|May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary FibrosisCathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|September 7, 2023
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung DiseaseFerhan Saleem, Christopher J Ryerson, Nandini Sarma, et al.
The European Respiratory Journal|March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registryNathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Annals of Internal Medicine|February 21, 2007
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialShawn D Aaron, Katherine L Vandemheen, Dean Fergusson, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2009
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trialMario Castro, Adalberto S Rubin, Michel Laviolette, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Chest|February 29, 2024
The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung DiseaseSabina A Guler, Daniel-Costin Marinescu, Gerard Cox, et al.
Respiratory Medicine|April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung diseaseGiulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Annals of the American Thoracic Society|December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung DiseaseAlyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Respiratory Medicine|December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune featuresSana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 4, 2023
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who surviveXiaotian Ju, Kiho Son, Rameen Jamil, et al.
Respirology (Carlton, Vic.)|May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary FibrosisCathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|September 7, 2023
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung DiseaseFerhan Saleem, Christopher J Ryerson, Nandini Sarma, et al.
The European Respiratory Journal|March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registryNathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Annals of Internal Medicine|February 21, 2007
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialShawn D Aaron, Katherine L Vandemheen, Dean Fergusson, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2009
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trialMario Castro, Adalberto S Rubin, Michel Laviolette, et al.
Pageof 9